Search research articles
Contact Us
Filters
Showing results (131-140 of 522) with videos related to
Page
of 53
Sort By:
Drug and Alcohol Review
|
October 11, 2014
Excess mortality among opioid-using patients treated with oral naltrexone in Australia
Louisa Degenhardt, Sarah Larney, Jo Kimber, et al.
Addiction (Abingdon, England)
|
June 14, 2020
Characteristics and circumstances of death related to the self-administration of ketamine
Shane Darke, Johan Duflou, Michael Farrell, et al.
Journal of Forensic Sciences
|
July 1, 2025
Characteristics and toxicology of adult deaths due to quetiapine toxicity in Australia, 2000-2024
Shane Darke, Johan Duflou, Julia Lappin, et al.
The Lancet. Public Health
|
October 14, 2018
Cannabis use and non-cancer chronic pain - Authors' reply
Gabrielle Campbell, Wayne Hall, Louisa Degenhardt, et al.
Neuroscience Letters
|
March 20, 2018
The minimal number of TMS trials required for the reliable assessment of corticospinal excitability, short interval intracortical inhibition, and intracortical facilitation
Mana Biabani, Michael Farrell, Maryam Zoghi, et al.
Drug and Alcohol Dependence
|
January 14, 2022
Characteristics of fatal 'novel' synthetic opioid toxicity in Australia
Shane Darke, Amy Peacock, Johan Duflou, et al.
Forensic Science International
|
December 11, 2021
Characteristics of fatal 'novel' benzodiazepine toxicity in Australia
Shane Darke, Amy Peacock, Johan Duflou, et al.
Drug and Alcohol Review
|
March 18, 2022
Characteristics of fatal tapentadol-related toxicity in Australia
Shane Darke, Johan Duflou, Amy Peacock, et al.
The American Surgeon
|
May 25, 2023
An Analysis of Outcomes After Trauma in Obstetric Patients
Danielle Hashmi, Michael Farrell, Lauren Salbinski, et al.
Drug and Alcohol Dependence
|
December 3, 2020
Characteristics and circumstances of death related to buprenorphine toxicity in Australia
Shane Darke, Johan Duflou, Briony Larance, et al.
Page
of 53
Search research articles
Search
Showing results (131-140 of 522) with videos related to
Sort By:
Page
of 53
Drug and Alcohol Review
|
October 11, 2014
Excess mortality among opioid-using patients treated with oral naltrexone in Australia
Louisa Degenhardt, Sarah Larney, Jo Kimber, et al.
Addiction (Abingdon, England)
|
June 14, 2020
Characteristics and circumstances of death related to the self-administration of ketamine
Shane Darke, Johan Duflou, Michael Farrell, et al.
Journal of Forensic Sciences
|
July 1, 2025
Characteristics and toxicology of adult deaths due to quetiapine toxicity in Australia, 2000-2024
Shane Darke, Johan Duflou, Julia Lappin, et al.
The Lancet. Public Health
|
October 14, 2018
Cannabis use and non-cancer chronic pain - Authors' reply
Gabrielle Campbell, Wayne Hall, Louisa Degenhardt, et al.
Neuroscience Letters
|
March 20, 2018
The minimal number of TMS trials required for the reliable assessment of corticospinal excitability, short interval intracortical inhibition, and intracortical facilitation
Mana Biabani, Michael Farrell, Maryam Zoghi, et al.
Drug and Alcohol Dependence
|
January 14, 2022
Characteristics of fatal 'novel' synthetic opioid toxicity in Australia
Shane Darke, Amy Peacock, Johan Duflou, et al.
Forensic Science International
|
December 11, 2021
Characteristics of fatal 'novel' benzodiazepine toxicity in Australia
Shane Darke, Amy Peacock, Johan Duflou, et al.
Drug and Alcohol Review
|
March 18, 2022
Characteristics of fatal tapentadol-related toxicity in Australia
Shane Darke, Johan Duflou, Amy Peacock, et al.
The American Surgeon
|
May 25, 2023
An Analysis of Outcomes After Trauma in Obstetric Patients
Danielle Hashmi, Michael Farrell, Lauren Salbinski, et al.
Drug and Alcohol Dependence
|
December 3, 2020
Characteristics and circumstances of death related to buprenorphine toxicity in Australia
Shane Darke, Johan Duflou, Briony Larance, et al.
Page
of 53